
|Articles|October 1, 2003
- Pharmaceutical Executive-10-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
Balanced Scorecard for R&Dover 22 years ago
Pharma's Value Propositionover 22 years ago
Sharing IP, Sharing RiskAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The New Healthy Aging Imperative and What It Means for Pharma
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
4
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
5




